{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:25:59Z","timestamp":1794453959535,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Rare genetic disorders (RGDs) often exhibit significant clinical variability among affected individuals, a disease characteristic termed variable expressivity. Recently, the aggregate effect of common variation, quantified as polygenic scores (PGSs), has emerged as an effective tool for predictions of disease risk and trait variation in the general population. Here, we measure the effect of PGSs on 11 RGDs including four sex-chromosome aneuploidies (47,XXX; 47,XXY; 47,XYY; 45,X) that affect height; two copy-number variant (CNV) disorders (16p11.2 deletions and duplications) and a Mendelian disease (melanocortin 4 receptor deficiency (\n                    <jats:italic>MC4R<\/jats:italic>\n                    )) that affect BMI; and two Mendelian diseases affecting cholesterol: familial hypercholesterolemia (FH;\n                    <jats:italic>LDLR<\/jats:italic>\n                    and\n                    <jats:italic>APOB<\/jats:italic>\n                    ) and familial hypobetalipoproteinemia (FHBL;\n                    <jats:italic>PCSK9<\/jats:italic>\n                    and\n                    <jats:italic>APOB<\/jats:italic>\n                    ). Our results demonstrate that common, polygenic factors of relevant complex traits frequently contribute to variable expressivity of RGDs and that\u00a0PGSs may be a useful metric for predicting clinical severity in affected individuals and for risk stratification.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-12869-0","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T14:52:58Z","timestamp":1572015178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders"],"prefix":"10.1038","volume":"10","author":[{"given":"M. T.","family":"Oetjens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-4210","authenticated-orcid":false,"given":"D. H.","family":"Ledbetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"12869_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(13)70011-5","volume":"12","author":"A Moreno-De-Luca","year":"2013","unstructured":"Moreno-De-Luca, A. et al. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. Lancet Neurol. 12, 406\u2013414 (2013).","journal-title":"Lancet Neurol."},{"key":"12869_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jacl.2014.05.002","volume":"8","author":"MTM Torres","year":"2014","unstructured":"Torres, M. T. M., Mora-Hern\u00e1ndez, S., C\u00e1rdenas, N. A. V. & Jaimes, A. G. Homozygous familial hypercholesterolemia: The c. 1055G> A mutation in the LDLR gene and clinical heterogeneity. J. Clin. Lipidol. 8, 525\u2013527 (2014).","journal-title":"J. Clin. Lipidol."},{"key":"12869_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature12818","volume":"505","author":"H Stefansson","year":"2014","unstructured":"Stefansson, H. et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505, 361\u2013366 (2014).","journal-title":"Nature"},{"key":"12869_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ajmg.a.38564","volume":"176","author":"MS Bateman","year":"2018","unstructured":"Bateman, M. S. et al. Incomplete penetrance, variable expressivity, or dosage insensitivity in four families with directly transmitted unbalanced chromosome abnormalities. Am. J. Med. Genet. A 176, 319\u2013329 (2018).","journal-title":"Am. J. Med. Genet. A"},{"key":"12869_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1107-9","volume":"17","author":"N Katsanis","year":"2016","unstructured":"Katsanis, N. The continuum of causality in human genetic disorders. Genome Biol. 17, 233 (2016).","journal-title":"Genome Biol."},{"key":"12869_CR6","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/hmg\/9.5.695","volume":"9","author":"M Clement-Jones","year":"2000","unstructured":"Clement-Jones, M. et al. The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum. Mol. Genet. 9, 695\u2013702 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"12869_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/03014467700001911","volume":"4","author":"CG Brook","year":"1977","unstructured":"Brook, C. G., Gasser, T., Werder, E. A., Prader, A. & Vanderschueren-Lodewykx, M. A. Height correlations between parents and mature offspring in normal subjects and in subjects with Turner\u2019s and Klinefelter\u2019s and other syndromes. Ann. Hum. Biol. 4, 17\u201322 (1977).","journal-title":"Ann. Hum. Biol."},{"key":"12869_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41588-018-0108-x","volume":"50","author":"LM Evans","year":"2018","unstructured":"Evans, L. M. et al. Comparison of methods that use whole genome data to estimate the heritability and genetic architecture of complex traits. Nat. Genet. 50, 737\u2013745 (2018).","journal-title":"Nat. Genet."},{"key":"12869_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1001\/jamapsychiatry.2014.2147","volume":"72","author":"A Moreno-De-Luca","year":"2015","unstructured":"Moreno-De-Luca, A. et al. The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. JAMA Psychiatry 72, 119\u2013126 (2015).","journal-title":"JAMA Psychiatry"},{"key":"12869_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nature10406","volume":"478","author":"S Jacquemont","year":"2011","unstructured":"Jacquemont, S. et al. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 478, 97\u2013102 (2011).","journal-title":"Nature"},{"key":"12869_CR11","doi-asserted-by":"crossref","unstructured":"Torkamani, A., Wineinger, N. E. & Topol, E. J. The personal and clinical utility of polygenic risk scores. Nat. Rev. Genet. 19, 581\u2013590 (2018).","DOI":"10.1038\/s41576-018-0018-x"},{"key":"12869_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrg.2016.27","volume":"17","author":"N Chatterjee","year":"2016","unstructured":"Chatterjee, N., Shi, J. & Garc\u00eda-Closas, M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat. Rev. Genet. 17, 392\u2013406 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"12869_CR13","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219\u20131224 (2018).","journal-title":"Nat. Genet."},{"key":"12869_CR14","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/s41436-018-0418-5","volume":"21","author":"NJ Wald","year":"2019","unstructured":"Wald, N. J. & Old, R. The illusion of polygenic disease risk prediction. Genet. Med. 21, 1705\u20131707 (2019).","journal-title":"Genet. Med."},{"key":"12869_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jacl.2017.03.019","volume":"11","author":"M Paquette","year":"2017","unstructured":"Paquette, M. et al. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia. J. Clin. Lipidol. 11, 725\u2013732.e5 (2017).","journal-title":"J. Clin. Lipidol."},{"key":"12869_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jacc.2019.05.043","volume":"74","author":"M Trinder","year":"2019","unstructured":"Trinder, M. et al. Risk of premature atherosclerotic disease in patients with monogenic versus polygenic familial hypercholesterolemia. J. Am. Coll. Cardiol. 74, 512\u2013522 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"12869_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/mp.2015.170","volume":"21","author":"KE Tansey","year":"2016","unstructured":"Tansey, K. E. et al. Common alleles contribute to schizophrenia in CNV carriers. Mol. Psychiatry 21, 1153 (2016).","journal-title":"Mol. Psychiatry"},{"key":"12869_CR18","doi-asserted-by":"publisher","unstructured":"Kuchenbaecker, K. B. et al. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers. J. Natl. Cancer Inst. 109, https:\/\/doi.org\/10.1093\/jnci\/djw302 (2017).","DOI":"10.1093\/jnci\/djw302"},{"key":"12869_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0566-4","volume":"562","author":"MEK Niemi","year":"2018","unstructured":"Niemi, M. E. K. et al. Common genetic variants contribute to risk of rare severe neurodevelopmental disorders. Nature 562, 268\u2013271 (2018).","journal-title":"Nature"},{"key":"12869_CR20","doi-asserted-by":"publisher","first-page":"e1002258","DOI":"10.1371\/journal.pmed.1002258","volume":"14","author":"RS Desikan","year":"2017","unstructured":"Desikan, R. S. et al. Genetic assessment of age-associated Alzheimer disease risk: development and validation of a polygenic hazard score. PLoS Med. 14, e1002258 (2017).","journal-title":"PLoS Med."},{"key":"12869_CR21","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/gim.2015.187","volume":"18","author":"DJ Carey","year":"2016","unstructured":"Carey, D. J. et al. The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research. Genet. Med. 18, 906\u2013913 (2016).","journal-title":"Genet. Med."},{"key":"12869_CR22","unstructured":"US Food and Drug Administration. Orphan Drug Act. https:\/\/www.fda.gov\/industry\/developing-products-rare-diseases-conditions (1983)."},{"key":"12869_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2012.94","volume":"21","author":"M Loane","year":"2013","unstructured":"Loane, M. et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur. J. Hum. Genet. 21, 27\u201333 (2013).","journal-title":"Eur. J. Hum. Genet."},{"key":"12869_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1056\/NEJMoa022050","volume":"348","author":"IS Farooqi","year":"2003","unstructured":"Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085\u20131095 (2003).","journal-title":"N. Engl. J. Med."},{"key":"12869_CR25","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274\u20131283 (2013).","journal-title":"Nat. Genet."},{"key":"12869_CR26","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","volume":"27","author":"L Yengo","year":"2018","unstructured":"Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in \u223c700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641\u20133649 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"12869_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00556-x","volume":"8","author":"A Mac\u00e9","year":"2017","unstructured":"Mac\u00e9, A. et al. CNV-association meta-analysis in 191,161 European adults reveals new loci associated with anthropometric traits. Nat. Commun. 8, 744 (2017).","journal-title":"Nat. Commun."},{"key":"12869_CR28","first-page":"1","volume":"3","author":"CD Fryar","year":"2016","unstructured":"Fryar, C. D., Gu, Q., Ogden, C. L. & Flegal, K. M. Anthropometric reference data for children and adults: United States, 2011-2014. Vital-. Health Stat. 3, 1\u201346 (2016).","journal-title":"Vital-. Health Stat."},{"key":"12869_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05747-8","volume":"9","author":"P Natarajan","year":"2018","unstructured":"Natarajan, P. et al. Deep-coverage whole genome sequences and blood lipids among 16,324 individuals. Nat. Commun. 9, 3391 (2018).","journal-title":"Nat. Commun."},{"key":"12869_CR30","unstructured":"Youngblom, E., et al. (University of Washington, Seattle, 2014)."},{"issue":"6319","key":"12869_CR31","doi-asserted-by":"publisher","first-page":"aaf7000","DOI":"10.1126\/science.aaf7000","volume":"354","author":"Noura S. Abul-Husn","year":"2016","unstructured":"Abul-Husn, N. S. et al. Genetic identification of familial hypercholesterolemia within a single U.S. health care system. Science 354, aaf7000 (2016).","journal-title":"Science"},{"issue":"1","key":"12869_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/emph\/eoy036","volume":"2019","author":"Noah A Rosenberg","year":"2018","unstructured":"Rosenberg, N. A., Edge, M. D., Pritchard, J. K. & Feldman, M. W. Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences. Evol. Med. Public Health (2018). https:\/\/doi.org\/10.1093\/emph\/eoy036","journal-title":"Evolution, Medicine, and Public Health"},{"key":"12869_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0022-3476(63)80368-6","volume":"63","author":"L Lemli","year":"1963","unstructured":"Lemli, L. & Smith, D. W. The XO Syndrome. A study of the differentiated phenotype in 25 patients. J. Pediatr. 63, 577\u2013588 (1963).","journal-title":"J. Pediatr."},{"key":"12869_CR34","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/adc.49.10.789","volume":"49","author":"CG Brook","year":"1974","unstructured":"Brook, C. G., M\u00fcrset, G., Zachmann, M. & Prader, A. Growth in children with 45,XO Turner\u2019s syndrome. Arch. Dis. Child. 49, 789\u2013795 (1974).","journal-title":"Arch. Dis. Child."},{"key":"12869_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28758-3","volume":"8","author":"BS Moore","year":"2018","unstructured":"Moore, B. S. & Mirshahi, T. Genetic variants help define the role of the MC4R C-terminus in signaling and cell surface stability. Sci. Rep. 8, 10397 (2018).","journal-title":"Sci. Rep."},{"key":"12869_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-8","volume":"5","author":"NR Tartaglia","year":"2010","unstructured":"Tartaglia, N. R., Howell, S., Sutherland, A., Wilson, R. & Wilson, L. A review of trisomy X (47,XXX). Orphanet J. Rare Dis. 5, 8 (2010).","journal-title":"Orphanet J. Rare Dis."},{"key":"12869_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s40618-016-0541-6","volume":"40","author":"M Bonomi","year":"2017","unstructured":"Bonomi, M. et al. Klinefelter syndrome (KS): genetics, clinical phenotype and hypogonadism. J. Endocrinol. Invest. 40, 123\u2013134 (2017).","journal-title":"J. Endocrinol. Invest."},{"key":"12869_CR38","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.ajhg.2018.03.012","volume":"102","author":"J Staples","year":"2018","unstructured":"Staples, J. et al. Profiling and leveraging relatedness in a precision medicine cohort of 92,455 exomes. Am. J. Hum. Genet. 102, 874\u2013889 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"12869_CR39","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1377\/hlthaff.2017.1557","volume":"37","author":"MS Williams","year":"2018","unstructured":"Williams, M. S. et al. Patient-centered precision health in a learning health care system: Geisinger\u2019s genomic medicine experience. Health Aff. 37, 757\u2013764 (2018).","journal-title":"Health Aff."},{"key":"12869_CR40","first-page":"e002146","volume":"11","author":"LK Jones","year":"2018","unstructured":"Jones, L. K. et al. Healthcare utilization and patients\u2019 perspectives after receiving a positive genetic test for familial hypercholesterolemia: a pilot study. Circulation: Genom. Precis. Med. 11, e002146 (2018).","journal-title":"Circulation: Genom. Precis. Med."},{"key":"12869_CR41","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1001\/jama.2017.1533","volume":"317","author":"MLB Schwartz","year":"2017","unstructured":"Schwartz, M. L. B., Williams, M. S. & Murray, M. F. Adding protective genetic variants to clinical reporting of genomic screening results: restoring balance. JAMA 317, 1527\u20131528 (2017).","journal-title":"JAMA"},{"key":"12869_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41436-018-0271-6","volume":"21","author":"MA Tuke","year":"2018","unstructured":"Tuke, M. A. et al. Mosaic Turner syndrome shows reduced penetrance in an adult population study. Genet. Med. 21, 877\u2013886 (2018).","journal-title":"Genet. Med."},{"key":"12869_CR43","unstructured":"Van Hout, C. V. et al. Whole exome sequencing and characterization of coding variation in 49,960 individuals in the UK Biobank. Preprint at: https:\/\/www.biorxiv.org\/content\/10.1101\/572347v1 (2019)."},{"key":"12869_CR44","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","volume":"169","author":"EA Boyle","year":"2017","unstructured":"Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177\u20131186 (2017).","journal-title":"Cell"},{"key":"12869_CR45","unstructured":"Dewey, F. E. et al. Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study. Science 354, aaf6814 (2016)."},{"key":"12869_CR46","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559\u2013575 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"12869_CR47","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ajhg.2014.10.005","volume":"95","author":"J Staples","year":"2014","unstructured":"Staples, J. et al. PRIMUS: rapid reconstruction of pedigrees from genome-wide estimates of identity by descent. Am. J. Hum. Genet. 95, 553\u2013564 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"12869_CR48","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at: https:\/\/arxiv.org\/abs\/1303.3997 (2013)."},{"key":"12869_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"12869_CR50","doi-asserted-by":"publisher","first-page":"D980","DOI":"10.1093\/nar\/gkt1113","volume":"42","author":"MJ Landrum","year":"2014","unstructured":"Landrum, M. J. et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 42, D980\u2013D985 (2014).","journal-title":"Nucleic Acids Res."},{"key":"12869_CR51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/bioinformatics\/btv547","volume":"32","author":"JS Packer","year":"2016","unstructured":"Packer, J. S. et al. CLAMMS: a scalable algorithm for calling common and rare copy number variants from exome sequencing data. Bioinformatics 32, 133\u2013135 (2016).","journal-title":"Bioinformatics"},{"key":"12869_CR52","doi-asserted-by":"crossref","unstructured":"Maxwell, E. K. et al. Profiling copy number variation and disease associations from 50,726 DiscovEHR Study exomes. Preprint at: https:\/\/www.biorxiv.org\/content\/10.1101\/119461v1.full (2017).","DOI":"10.1101\/119461"},{"key":"12869_CR53","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/ng.3679","volume":"48","author":"P-R Loh","year":"2016","unstructured":"Loh, P.-R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet. 48, 1443\u20131448 (2016).","journal-title":"Nat. Genet."},{"key":"12869_CR54","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284\u20131287 (2016).","journal-title":"Nat. Genet."},{"key":"12869_CR55","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665\u20131674 (2007).","journal-title":"Genome Res."},{"key":"12869_CR56","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.ajhg.2016.05.014","volume":"98","author":"JP Dumanski","year":"2016","unstructured":"Dumanski, J. P. et al. Mosaic loss of chromosome Y in blood is associated with Alzheimer disease. Am. J. Hum. Genet. 98, 1208\u20131219 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"12869_CR57","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ajhg.2015.09.001","volume":"97","author":"BJ Vilhj\u00e1lmsson","year":"2015","unstructured":"Vilhj\u00e1lmsson, B. J. et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am. J. Hum. Genet. 97, 576\u2013592 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"12869_CR58","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","volume":"374","author":"FE Dewey","year":"2016","unstructured":"Dewey, F. E. et al. Inactivating variants in ANGPTL4 and risk of coronary artery disease. N. Engl. J. Med. 374, 1123\u20131133 (2016).","journal-title":"N. Engl. J. Med."},{"key":"12869_CR59","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1745-9125.1998.tb01268.x","volume":"36","author":"R Paternoster","year":"1998","unstructured":"Paternoster, R., Brame, R., Mazerolle, P. & Piquero, A. Using the correct statistical test for the equality of regression coefficients. Criminology 36, 859\u2013866 (1998).","journal-title":"Criminology"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12869-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:05:23Z","timestamp":1695341123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-12869-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["12869"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-12869-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"14 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.H.L. is a scientific consultant to Clear Genetics, Inc. and Natera, Inc. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4897"}}